Paul Copeland, MD
Clinical Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Medicine
General Internal Medicine

MD, Yale University
MPhil, Yale University
MA, Yale University



Dr. Paul Copeland, MD is an endocrinology, diabetes & metabolism specialist in Lynn, MA and has been practicing for 35 years. He graduated from Yale University in 1978 and specializes in endocrinology, diabetes & metabolism and internal medicine.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957.View Related Profiles. PMID: 30747254
     
  2. Luo Y, Liu F, Natarajan R, Shukair N, Copeland P, Fan X. Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a pilot study. Int Clin Psychopharmacol. 2018 03; 33(2):88-91. PMID: 29084087; PMCID: PMC5794614; DOI: 10.1097/YIC.0000000000000204;
     
  3. Nemani KL, Greene MC, Ulloa M, Vincenzi B, Copeland PM, Al-Khadari S, Henderson DC. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. Clin Schizophr Relat Psychoses. 2019; 12(4):168-176.View Related Profiles. PMID: 29164928; PMCID: PMC6489443; DOI: 10.3371/CSRP.KNMG.111717;
     
  4. Henderson DC, Vincenzi B, Andrea NV, Ulloa M, Copeland PM. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015 May; 2(5):452-464.View Related Profiles. PMID: 26360288; DOI: 10.1016/S2215-0366(15)00115-7;
     
  5. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403.View Related Profiles. PMID: 25261882; PMCID: PMC4311769; DOI: 10.1016/j.schres.2014.08.021;
     
  6. Vincenzi B, Borba CP, Gray DA, Copeland PM, Wang X, Fan X, Aragam GG, Henderson DC. An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics. Ann Clin Psychiatry. 2013 May; 25(2):141-8.View Related Profiles. PMID: 23638445
     
  7. Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30.View Related Profiles. PMID: 23422397; PMCID: PMC5366038; DOI: 10.1097/JCP.0b013e31828701d0;
     
  8. Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5.View Related Profiles. PMID: 23434504; PMCID: PMC3622829; DOI: 10.1016/j.schres.2013.01.034;
     
  9. Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26.View Related Profiles. PMID: 22943577; PMCID: PMC4327765; DOI: 10.1111/acps.12009;
     
  10. Borba CP, Fan X, Copeland PM, Paiva A, Freudenreich O, Henderson DC. Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. J Clin Psychopharmacol. 2011 Oct; 31(5):653-8.View Related Profiles. PMID: 21869685; PMCID: PMC3725551; DOI: 10.1097/JCP.0b013e31822bb573;
     
Showing 10 of 42 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 42 publications over 22 distinct years, with a maximum of 6 publications in 2009

YearPublications
19831
19841
19861
19871
19882
19892
19952
19971
20041
20054
20065
20072
20096
20101
20113
20121
20133
20141
20151
20171
20181
20191

Contact for Mentoring:

670 Albany St
Boston MA 02118
Google Map


Copeland's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department